These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 33839701

  • 1. Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma.
    Yao B, Wang L, Wang H, Bao J, Li Q, Yu F, Zhu W, Zhang L, Li W, Gu Z, Fei K, Zhang P, Zhang F, Huang X.
    Aging (Albany NY); 2021 Apr 04; 13(8):11381-11410. PubMed ID: 33839701
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X, Hu Z, Huang C, Chang J.
    Med Sci Monit; 2020 Jul 02; 26():e924269. PubMed ID: 32613949
    [Abstract] [Full Text] [Related]

  • 5. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
    Chen G, Dong Z, Wu D, Chen Y.
    J Cell Biochem; 2020 Nov 02; 121(11):4431-4439. PubMed ID: 32003059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M, Li M, Chen Z, Bian Y, Zheng Y, Hu Z, Liang J, Huang Y, Yin J, Zhan C, Feng M, Wang Q.
    Immunogenetics; 2020 Dec 02; 72(9-10):455-465. PubMed ID: 33188484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
    Zhai Y, Zhao B, Wang Y, Li L, Li J, Li X, Chang L, Chen Q, Liao Z.
    BMC Cancer; 2021 Mar 01; 21(1):213. PubMed ID: 33648465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
    Sun S, Guo W, Wang Z, Wang X, Zhang G, Zhang H, Li R, Gao Y, Qiu B, Tan F, Gao Y, Xue Q, Gao S, He J.
    Cancer Med; 2020 Aug 01; 9(16):5960-5975. PubMed ID: 32592319
    [Abstract] [Full Text] [Related]

  • 16. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.
    Jiang H, Xu S, Chen C.
    BMC Cancer; 2020 Aug 20; 20(1):782. PubMed ID: 32819300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exploring exosome data to identify prognostic gene signatures for lung adenocarcinoma.
    Li J, Gao X, Tian S, Tang M, Liu W.
    Future Oncol; 2021 Dec 20; 17(34):4745-4756. PubMed ID: 34658257
    [Abstract] [Full Text] [Related]

  • 20. A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients.
    Ma C.
    Curr Med Chem; 2024 Dec 20; 31(38):6319-6335. PubMed ID: 38529604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.